Amanda Wooding is an Investment Director at Cambridge Enterprise, where they focus on helping innovators and entrepreneurs at the University of Cambridge achieve commercial success. With a robust career spanning charitable, corporate, and academic sectors, Amanda has developed expertise in business development, technology licensing, and start-up creation in the life sciences. They have held directorial roles at several organizations, including PredictImmune and Kalium Health, and previously served as a Director of Business Development at Acambis Research Limited. Amanda earned a Ph.D. in Insulin Signalling from the University of Cambridge.
Location
Cambridge, United Kingdom